A dual FISH assay for detectin deletions associated with VCFSDiGwrge syndrome I and Di2eorge syndrome 11 loci. SA m l , R K Holmeul.WJ Crdipenl. AS Spikes1. C D Kashork'. JM WZ
DiGeorge syndrome (DGS) is a developmental field defect of the 3rd and 4th pharyngeal pouches. This syndmme is characterized by dysmorphic features, h oplasia of the thymus and parathyroid glands, and conotruncal heart a e c t s . Over 90% o f patients with the syndrome have a micmdeletion at 22q11.2. This deletion occurs i n about I i n 4000 live births. Since these deletions are difficult to visualize at the light microscopic level, fluorescence in sifu hybridization (FISH) has been instrumental i n the diagnosis of this disorder. Another less frequent chromosomal abnormality associated with the DGS phenotype is a deletion at 10p13p14. Since both deletions are associated with a sim~lar phenotype, we have developed a dual FISH assay i n our laboratory for screening samples referred for DGS or velocardiofacial syndrome (VCFS). This assay includes two test probes: a cosmid (F5) located i n the DGSl critical reglon on chmmosome 22, a PAC (72-A7) that is contained within the DGSII critical region on chmmosome 10, and control probes specific for chromosomes 10 and 22. Since 1996, over 400 patlents have been tested with the dual FISH assay. Recently, one patient was identified who was deleted for the DGSII locus at 10p13p14. This child had facial features of VCFS, sensorineural hearing loss, and renal anomalies. Cytogenetic analysis revealed a large deletion of 10p [46, XX, de1(10) 12 2p14)l and FISH using a 10p telomerespecific pmhe confirm3the interstitial nature of the deletion. The identification of this case mmpted us to review the results of samples submitted to our laboratory &r the dual probe assay. 412 patients have been screened with the dual assay and 54 were found to be deleted for 22q11.2 (13%), whereas only one patient was found to be deleted for the locus o n chromosome 10 (0.24%). Hence, the deletion on chromosome 10p may he 50 times less frequent than the deletion on chmmosome 22. B a s y o n a frequen? of 22q11.2 deletions of 1 i n 4000, the incidence o f delet~ons i n the DG II cr~ttcal reglon on chmmosome 10 is estimated to he about I i n 200,000. Ind~viduals carrying balanced translocations may have offspringwith unbalanced karyotypes. This may result in symptoms ranging from mild to severe mental retardation with multiple congenital defects depending, on the chromosomes involved. We are reporting two very interesting chromosomal abnormalities detected postnatally. after the infants were referred for genetic evaluation. Both mothers had amniocentesis: the fust because of abnormalities detected on ultrasound and the second because of a previous child with anomalies and because of advanced maternal age. The fust was interpreted as showing a balanced translocation and the second as normal The first case involves a child whose mother carried a 3 way reciprocal translocation. The child inherited 2 of the 3 maternal derivatives resulting in an unbalanced chromosome complement, which in turn created multlple congenital anomalies that were incompatible with Ilfe. The second child's mother had a reciprocal translocation involving chromosomes 19 and 21. The child inherited an abnormal chromosome 21, a derivative secondary to the maternal translocation. This abnormality resulted in both a deletion of a pan of the long arm of chromosome 21 and a duplication of a portion of the long arm of chromosome 19. Reevaluation of the chromosome analysis obtained by amniocentesis from the first pregnancy in whlch the child had a diaphragmatic hernia showed the same chromosome abnormality Both abnormalities were identified posmatally with the use of FISH This case illustrates the importance of careful genetics follow up of infants with anomalies.
A patient w~t h Gorlin-Chaudhry-Moss syndrome and de1 (9) We report a patient with a rare 9q deletion and features of Gorlin-Chaudhry-Moss syndrome (CCM). At age 3, the patient presented with acrocephaly, small maxilla, low frontal hairline, two occipital hair whorls, epicanthal folds, hypotelorism and prominent eyes w~t h strabismus and nystagmus, and oval irides. She also had synophrys, low set ears, a tuft of hair on her nose, cleft tip of the nose, thin upper lip, downturned corners of the mouth, high arched palate, webbing between the gums and buccal mucosa, wide alveolar ridge and dental anomalies including fusion of some teeth, mrld pectus excavatum, 5th finger clinodactyly, left transverse palmar crease, short 4Ih metacarpals, overlapping toes 2-3, and thoracic scoliosis. She had persistent rhinorrhea and serous otitis media requiring PE tubes. She was not waking or taking. Karyotype was 46,XX,de1(9)(q22,Iq22 3). Mother's karyotype was normal and father was unavailable. CT scan rdentified ageoesis of the corpus callosum. At age 21 she had moderate mental retardation and spoke in short phrases with unclear speech. Numerous scars on her anns were secondary to skin picking. Surgeries included spinal fusroo with Harrington rod placement and removal of 5 odontogenic cysts. Right retinal detachment and cataract had occurred and she continued to have rhinorrhea and serous otitis. Acrocephaly, coarse facies, shallow orbits with prominent eyes, oval ]rides, synophrys, right ptosis, midface hypoplasia, prominent chin, hypodontia, short 4' metacarpals, and hypoplastic and dysplastic fmger and toenails were noted.
GCM was first reported in sisters with craniofacial dysostosis, hypertrichosis, dental and eye anomalies, patent ductus arterrosus, and mental retardation. Other features included short 4* metacarpals and distal phalanges. Two other unrelated females have been identified and all four patients had hypertrichosis, low frontal hairline, conductive hearing loss, and coarsenrng of facial features with time. Autosomal recessive inheritance was postulated.
We are unaware of other subjects with this deletion though 9q22-q32 deletions have been reported to have mental retardation. seizures, hypotelorism, sclerocornea, duodenal atresra, malrotation, hydronephrosis, preaxral polydactyly and syndactyly of the toes. Our findings suggest that GCM may represent a contiguous gene syndrome resrdrng wlthin the 9q22.1-q2Z 3 segment. Our patient's more severe mental retardation may be secondary to deletron of other genes on 9q
Karyotyping miscarriage tissue in the managed care environment. E.M. Karson Columbia Hosp for Women, Washington, DC.
Various economic faclors have lead to the emergence of large corporate laboratories and perishable cytogenetic specimens are directed away from inhospital and nearby local andresional university laboratories to distant,designated sites. Most amniocentesis and blood specimens have sufficient numbers of viable cells to withstand 24 to 72 hour transport if protected from extreme heat or freezing. Specimens of miscarriage tissues, known as products of conception (POC's) autolyze rapidly andlor kame contaminated by the normal vaginal flora if not placed immediately in sol~uons contalnlng anbbiotics and constdy refrigeratea In add'lion, as specimen deter orate. 11 becomes increaangly difficult to cleanlng . . separate away contaminating maternal deddua tissue.
The majority of first and early second trimester pregnancy losses are a reall! nf -.. -.
abnormal karyotype n the conceptds The major purpose foi perform~ng karyotypes on POC's is lo d~fferent ate lhose women whose loss (often recurrent losses) 2ra nf -, --.
normal karyotype conception and who may require other evaluation and inthention, those who may be carriers of translocations who need to be counseled that future pregnancies may result in continued losses or even h e birth of offspring impaired by an unbalanced chromosome complement, and finally those for whom the ane~bnlnid ,,,,",-event was sporadic and future pregnancies are likely to succeed without special intervention. When the POC karyotype is erroneously reported as ' 46, XX -normal female' because maternal rather than conceptus cells predominate in culture, the subsequent counseling will be inaccurate and medical interventions offered to the patient may be inappropriate or even harmful. Depending on the true karyotype, the treatment error may be omission or excess. In the past 2 years, as more specimens from oulpatient dilatation and curettage procedures were directed to laboratories, a distinct change in the patterns of results was observed. If one postulates that h e karyotype should not be vary by the patient insurance company, one would expect a similar rate of successful culture and distribution of abnormal karyotypes in the outsourced specimens. What has been pbserved is a significant increase in h e number of 'non-viable' specimens and normal female' karyotypes compared to specimens that were allowed to remain in the hospital cytogenetics laboratory for processing. The patterns of karyotypes seen and hypotheses for these variations will be discussed. 
